Synthesis of Substituted Aryl Incorporated Oxazolo[4,5-b]Pyridine-Triazole Derivatives: Anticancer Evaluation and Molecular Docking Studies

被引:16
|
作者
Sireesha, Reddymasu [1 ]
Tej, Mandava Bhuvan [2 ]
Poojith, Nuthalapati [3 ]
Sreenivasulu, Reddymasu [4 ]
Musuluri, Murali [5 ]
Subbarao, Mannam [1 ]
机构
[1] Acharya Nagarjuna Univ, Dept Chem, Guntur 522510, Andhra Pradesh, India
[2] Sri Ramachandra Inst Higher Educ & Res, Dept Pharm, Chennai, Tamil Nadu, India
[3] PJ Biousys LLC, Irving, TX USA
[4] Jawaharlal Nehru Technol Univ, Univ Coll Engn Autonomous, Dept Chem, Kakinada, Andhra Pradesh, India
[5] RVR & JC Coll Engn, Dept Chem, Guntur, Andhra Pradesh, India
关键词
1; 2; 3-Triazoles; Anticancer activity; hDHODH; Molecular docking; Oxazolo[4; 5-b]pyridine; BIOLOGICAL EVALUATION; ANTIMICROBIAL EVALUATION; ELLIPTICINE DERIVATIVES; INHIBITORY-ACTIVITY; AMIDE DERIVATIVES; DESIGN; ANALOGS; POTENT; DISCOVERY; BINDING;
D O I
10.1080/10406638.2021.2021256
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new series of structurally modified oxazolo[4,5-b]pyridine based triazoles (18a-j) derivatives were synthesized, and designed and screened for their anticancer activities against human cancer cell lines like PC3 (prostate), A549 (lung), MCF-7 (breast), and DU-145 (prostate) by using MTT assay method. Most of the tested compounds exhibited good to moderate anticancer potential in comparison with etoposide. Among all, compounds 18a, 18b, 18c, 18d, 18e, and 18i displayed promising anticancer activities on four cell lines. Furthermore, molecular docking studies were carried out on human dihydroorotate dehydrogenase (hDHODH), a potential target for anticancer drugs, that is linked to proliferation, invasion, and migration of cancerous cell in acute myeloid leukemia, colorectal cancer melanoma, and pancreatic cancer cells. The investigated oxazolo[4,5-b]pyridine-based triazoles (18a-j) showed efficient inhibition of hDHODH in molecular docking studies.
引用
收藏
页码:915 / 932
页数:18
相关论文
共 50 条
  • [21] QSAR studies of imidazo[4,5-b]pyridine derivatives as anticancer drugs using RASMS method
    Tong, Jianbo
    Zhao, Xiang
    Zhong, Li
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (11) : 4883 - 4892
  • [22] QSAR studies of imidazo[4,5-b]pyridine derivatives as anticancer drugs using RASMS method
    Jianbo Tong
    Xiang Zhao
    Li Zhong
    Medicinal Chemistry Research, 2014, 23 : 4883 - 4892
  • [23] Synthesis and reactivity of 2-(2-thienyl)oxazolo[4,5-b]pyridine
    Aleksandrov, A. A.
    El'chaninov, M. M.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2015, 85 (04) : 858 - 860
  • [24] Quantum chemical study on excited states and charge transfer of oxazolo[4,5-b]-pyridine derivatives
    RongXing He
    YanJie Yuan
    Wei Shen
    Ming Li
    Li Yao
    Science China Chemistry, 2012, 55 : 2186 - 2196
  • [26] Multivariate Regression Modelling of Antifungal Activity of Some Benzoxazole and Oxazolo[4,5-b]pyridine Derivatives
    Kovacevic, Strahinja Z.
    Kuzmanovic, Sanja O. Podunavac
    Jevric, Lidija R.
    ACTA CHIMICA SLOVENICA, 2013, 60 (04) : 756 - +
  • [27] Quantum chemical study on excited states and charge transfer of oxazolo[4,5-b]-pyridine derivatives
    He RongXing
    Yuan YanJie
    Shen Wei
    Li Ming
    Yao Li
    SCIENCE CHINA-CHEMISTRY, 2012, 55 (10) : 2186 - 2196
  • [28] Synthesis of new imidazo-[4,5-b]pyridine derivatives
    Bukowski L.
    Chemistry of Heterocyclic Compounds, 2002, 38 (07) : 828 - 835
  • [29] Quantum chemical study on excited states and charge transfer of oxazolo[4,5-b]-pyridine derivatives
    HE RongXing YUAN YanJie SHEN Wei LI Ming YAO Li College of Chemistry and Chemical Engineering Southwest University Chongqing China Department of Physics Dalian Maritime University Dalian China
    Science China(Chemistry), 2012, 55 (10) : 2186 - 2196
  • [30] Green synthesis, spectroscopic investigation, quantum chemical and molecular docking studies of 3-methylisoxazolo [4,5-b]pyridine
    Dhanalakshmi, E.
    Rajesh, P.
    Suresh, S.
    Priyadharshini, M.
    Prabhaharan, M.
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1298